/MCVEF

MCVEF Stock - Medicover AB (publ)

Q: What is the analyst price target for MCVEF?

Analyst price target information is not currently available for MCVEF.

Q: What is MCVEF's market cap?

Market capitalization information is not currently available for MCVEF.

Healthcare|Medical - Care Facilities|OTC

$27.25+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $29.98

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for MCVEF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.76

52W High$27.25

52W Low$15.05

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$2.09B	$1.75B	$1.51B	$1.38B	$997.80M
Gross Profit	$448.30M	$359.40M	$335.60M	$395.00M	$263.50M
Gross Margin	21.4%	20.6%	22.2%	28.7%	26.4%
Operating Income	$70.30M	$61.40M	$55.50M	$159.40M	$61.30M
Net Income	$16.70M	$17.60M	$11.80M	$101.80M	$25.80M
Net Margin	0.8%	1.0%	0.8%	7.4%	2.6%
EPS	$0.11	$0.12	$0.08	$0.67	$0.19

Company Overview

Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company operates 97 clinical laboratories, 733 blood-drawing points, and 26 clinics in 10 countries; and 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Visit Website

Earnings History & Surprises

MCVEF

Beat Rate

44%

Last 16 quarters

Avg Surprise

-5.9%

EPS vs Estimate

Beats / Misses

7/9

Last 12 quarters

Latest EPS

$0.18

Q4 2025

EPS Surprise History

Q1 24

+175.9%

$0.09vs$0.03

Q2 24

+36.8%

$0.04vs$0.03

Q3 24

-29.8%

$0.05vs$0.06

Q4 24

-141.2%

$-0.03vs$0.08

Q1 25

+39.8%

$0.06vs$0.04

Q2 25

+51.5%

$0.15vs$0.10

Q3 25

+6.0%

$0.15vs$0.14

Q4 25

+32.1%

$0.18vs$0.13

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	Apr 27, 2026	—	—	—	—
Q1 2026	Feb 10, 2026	—	—	—	—
Q4 2025	Nov 5, 2025	$0.13	$0.18	+32.1%	✓ BEAT
Q3 2025	Jul 24, 2025	$0.14	$0.15	+6.0%	✓ BEAT
Q2 2025	Apr 29, 2025	$0.10	$0.15	+51.5%	✓ BEAT
Q1 2025	Feb 12, 2025	$0.04	$0.06	+39.8%	✓ BEAT
Q4 2024	Oct 30, 2024	$0.08	$-0.03	-141.2%	✗ MISS
Q3 2024	Jul 25, 2024	$0.06	$0.05	-29.8%	✗ MISS
Q2 2024	Apr 26, 2024	$0.03	$0.04	+36.8%	✓ BEAT
Q1 2024	Feb 9, 2024	$0.03	$0.09	+175.9%	✓ BEAT
Q3 2023	Sep 30, 2023	$0.05	$-0.01	-113.3%	✗ MISS
Q2 2023	Jun 30, 2023	$0.19	$0.04	-79.1%	✗ MISS
Q1 2023	Mar 31, 2023	$0.19	$0.01	-94.3%	✗ MISS
Q1 2023	Feb 17, 2023	$0.15	$0.01	-90.8%	✗ MISS
Q4 2022	Nov 3, 2022	$0.01	$-0.02	-340.8%	✗ MISS
Q3 2022	Jul 22, 2022	$0.02	$0.01	-49.8%	✗ MISS
Q2 2022	Apr 27, 2022	—	$0.09	—	—
Q1 2022	Feb 11, 2022	$-0.06	$0.24	+520.4%	✓ BEAT
Q4 2021	Nov 3, 2021	$0.20	$0.16	-17.6%	✗ MISS
Q3 2021	Jul 23, 2021	—	$0.24	—	—

Frequently Asked Questions about MCVEF

What is MCVEF's current stock price?

Medicover AB (publ) (MCVEF) is currently trading at $27.25 per share. The stock has moved +0.00% today.

What is the analyst price target for MCVEF?

No analyst price targets are currently available for this stock.

What sector is Medicover AB (publ) in?

Medicover AB (publ) operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the OTC exchange.

What is MCVEF's market cap?

Medicover AB (publ) has a market capitalization of $4.12 billion, making it a mid-cap company.

Does MCVEF pay dividends?

No, Medicover AB (publ) does not currently pay a dividend to shareholders.